Literature DB >> 591643

Serum protein changes in breast cancer: a prospective study.

K W Pettingale, D E Tee.   

Abstract

Sixty women admitted to the King's College Hospital group for biopsy of a lump in the breast have been followed sequentially for one year. Thirty women had early operable breast cancer and 30 had benign breast disease. Each patient had 10 serum proteins measured preoperatively and postoperatively at three months and at one year. The patients with breast cancer had significantly higher levels of beta2 glycoprotein preoperatively and caeruloplasmin at one year postoperatively than those with benign breast disease. There were a number of significant correlations between serum protein levels and the progression of breast cancer as measured by the clinical score. There were significant correlations with caeruloplasmin preoperatively and at three months postoperatively. Prealbumin and haemopexin showed correlations preoperatively; alpha1 antitrypsin and beta2 glycoprotein only correlated at three months postoperatively. A longer follow-up will be required to establish the value of serum protein changes which could predict the development of metastases in patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 591643      PMCID: PMC476645          DOI: 10.1136/jcp.30.11.1048

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  An evaluation of the diagnostic value of haptoglobin and transferrin levels in serum.

Authors:  G J Douma; A van Dalen
Journal:  Z Klin Chem Klin Biochem       Date:  1974-10

2.  Alpha-2 globulin "spike" in renal carcinoma.

Authors:  P McPhedran; S C Finch; Y R Nemerson; M G Barnes
Journal:  Ann Intern Med       Date:  1972-03       Impact factor: 25.391

3.  Quantitation of specific serum glycoproteins in malignancy.

Authors:  S Snyder; G Ashwell
Journal:  Clin Chim Acta       Date:  1971-10       Impact factor: 3.786

4.  Local excision and irradiation: an alternative method for the treatment of early mammary cancer.

Authors:  L Wise; A Y Mason; L V Ackerman
Journal:  Ann Surg       Date:  1971-09       Impact factor: 12.969

5.  [Genetic studies on the deficiency of beta 2-glycoprotein I of human serum].

Authors:  H Cleve
Journal:  Humangenetik       Date:  1968

6.  The seromucoid glycoprotein sub-fraction in pregnancy and the early puerperium.

Authors:  W Good; K W Hancock; H N Macdonald
Journal:  J Obstet Gynaecol Br Commonw       Date:  1971-07

7.  Qualitative and quantitative alterations in serum serumucoid in malignant neoplastic disease.

Authors:  H Bacchus; E R Kennedy; J Balckwell
Journal:  Cancer       Date:  1967-10       Impact factor: 6.860

  7 in total
  3 in total

1.  Must plagiarism thrive?

Authors: 
Journal:  Br Med J       Date:  1980-07-05

2.  Serum proteins as tumour markers for breast cancer.

Authors:  P Mattison; D H Cove; L Walsh; A Howell; B McConkey; J M Morrison
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

3.  Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.

Authors:  Liping Chung; Katrina Moore; Leo Phillips; Frances M Boyle; Deborah J Marsh; Robert C Baxter
Journal:  Breast Cancer Res       Date:  2014-06-16       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.